Zhejiang Starry Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 364.080 million compared to CNY 291.493 million a year ago. Operating income was CNY 79.927 million compared to CNY 62.035 million a year ago. Net income was CNY 64.571 million compared to CNY 45.655 million a year ago. Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 0.19 a year ago.